Investor Relations

SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and ... More »

 Corporate Presentation

 Stipulation of Settlement
 Preliminary Notice of Proposed Settlement

Recent Releases

Jan 9, 2012
SciClone Provides 2011 Financial Update and Initial 2012 Guidance

Dec 15, 2011
SciClone Pharmaceuticals Announces Final Settlement of Stockholder Derivative Litigation

View all releases »

Events & Presentations

Mar 12, 2012 at 10:30 AM PT
Phacilitate's Rare Disease Leaders' Forum

Nov 30, 2011 at 3:30 PM ET
Piper Jaffray Healthcare Conference

View all events & presentations »